About
Vyne Therapeutics Inc (NASDAQ:VYNE) — investor relations, events, news, and company updates on 6ix.
Latest News
Dec 17 2025
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement
Dec 17 2025
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement
Nov 6 2025
VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update
Aug 14 2025
VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update
Jul 30 2025
VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo
Financials
Revenue
$570 K
Market Cap
$20.12 M
EPS
-0.63
